Investigate / CBOE
Understand Cboe Global Markets, Inc.
Can Cboe's options and volatility franchise remain protected and productive while it narrows its global footprint?
Snapshot reviewed 2026-10-02. Source published 2026-07-31. No account needed.
AI-assisted synthesis of selected public filings, checked against the cited excerpts. Not a complete analysis.
This is a research starting point, not a buy/sell recommendation or a current valuation. New developments after these sources are not incorporated automatically.
Ownership-page coverage is not available for this company. That does not mean no tracked investor owns it.
Your research workspace / CBOE
Ask better questions. Keep the evidence.
Explore the available sources for Cboe Global Markets, Inc., then keep what deserves another look.
01 Investor activity
Ownership coverage is unavailable—not zero owners.
02 Business evidence
Reported evidence
What does the company do?
Cboe provides trading and clearing solutions in equities, derivatives and foreign-exchange markets across North America, Europe and Asia Pacific.
Latticework interpretation
What could support the case?
If exclusive index licenses and proprietary VIX-methodology rights are maintained, they could support Cboe’s revenue after cost of revenues.
Latticework interpretation
What could break the case?
If an index owner does not renew an exclusive license, Cboe could lose that license or face competing listings.
03 Questions to investigate
Open saved takeaways →Read the full company brief
1. Understand the business
Cboe provides trading and clearing solutions in equities, derivatives and foreign-exchange markets across North America, Europe and Asia Pacific.
Source: Annual filing · business description ↗2. What the reported results show
Latest source: 10-Q, reporting period ended 2026-06-30. Selected reported US-GAAP/USD comparisons. The period and basis of each measure are shown separately; year-to-date cash flow is not a quarterly figure. Missing comparisons are collection gaps, not evidence that a company has no revenue or earnings.
| Measure | Current | Prior year |
|---|---|---|
| Operating income ↗Quarter: 2026-04-01–2026-06-30; prior 2025-04-01–2025-06-30Both values reported in the current filing. | $476m | $339.1m |
| Net income ↗Quarter: 2026-04-01–2026-06-30; prior 2025-04-01–2025-06-30Both values reported in the current filing. | $353.1m | $235.1m |
| Operating cash flow ↗Six months (year to date): 2026-01-01–2026-06-30; prior 2025-01-01–2025-06-30Both values reported in the current filing. Operating cash flow is not free cash flow or a standalone solvency assessment; inspect the full statement. | $1,456.8m | $1,246.6m |
Comparison caveat: The prior-year quarter includes a Cboe Japan intangible-asset impairment. Separate its absence from recurring operating improvement and inspect the business-exit disclosures.
10-Q · latest checked financial statements and discussion ↗3. The investment debate
Latticework interpretation of the reported results—not the stated motives of any investor.
What could support the case
If exclusive index licenses and proprietary VIX-methodology rights are maintained, they could support Cboe’s revenue after cost of revenues.
Supporting filing ↗The strongest caution
If an index owner does not renew an exclusive license, Cboe could lose that license or face competing listings.
Caution evidence ↗An interesting business is not necessarily an attractive investment at today's price. Price, dilution, financing terms and a valuation range still need investigation.
Inspect the evidence behind both sides ↗4. Three questions worth investigating
Use these to guide your research, not as conclusions that have already been proved.
How exposed is Cboe to licence renewal?
Starting evidence: Cboe describes revenue after cost of revenues as dependent in large part on exclusive index licenses and proprietary VIX-methodology rights.
Investigate next: Review licence terms, renewal dates and any disclosed history of renewals or competing listings.
Read the supporting filing ↗Does the portfolio pruning improve focus?
Starting evidence: The annual filing describes initiated winddowns and sales processes following a global strategic review.
Investigate next: Compare retained versus exited segment results and stated costs of the realignment in later filings.
Read the supporting filing ↗Could new prediction products matter?
Starting evidence: Cboe launched binary-option contracts in its Cboe Predicts prediction-market suite.
Investigate next: Look for disclosed volumes, regulatory constraints and competing offerings for these contracts.
Read the supporting filing ↗5. Decide what to do next
Worth another look? Save this company and return to the evidence. Writing a private view is optional. You do not need to decide whether to invest today.
Save is on this device. Recording a private view requires sign-in and an explicit save. Neither action subscribes you to email or automatically evaluates your thesis.